Award

Pharmaceutical Sciences and Pharmacogenomics

Description: There is an increasing need for the development of new and effective drug therapies for the treatment of disease that can be tailored for individual patients. Students in the Pharmaceutical Sciences and Pharmacogenomics Graduate Program are trained to be future scientific leaders in this area. Their training will prepare them to develop effective treatment strategies for existing and newly developed drugs that consider the principles of pharmacology and our advancing knowledge of personal genetics.
Funding type: training
Funder scheme: T32
Start date: 1982-07-01
End date: 2022-08-31
Investigator: NADAV AHITUV
Institution: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Funded outputs count: 354
Funder award ID: T32GM007175
OpenAlex ID: G8578516764
2024 · Stefanie D. Pina‐Escudero, Renaud La Joie, et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 10
2024 · Joaquín Migeot, Carolina Panesso, et al. · Neuroscience & Biobehavioral Reviews · 25
2024 · Anu Patel, Sarah B. Doernberg, et al. · Clinical Pharmacology & Therapeutics · 7
2023 · Michelle Wang, Madhumita Sushil, et al. · Journal of the American Medical Informatics Association · 20
2022 · Ian R Jones, Xingjie Ren, et al. · Human Molecular Genetics · 8
2022 · Hwi-yeol Yun, Min Jung Chang, et al. · Antimicrobial Agents and Chemotherapy · 6
2022 · Payal B. Watchmaker, Maggie Colton, et al. · Current Opinion in Oncology · 2
2022 · Marcus Y. Chin, Kean-Hooi Ang, et al. · ACS Chemical Neuroscience · 18
2022 · Megan Lo, Amnon Sharir, et al. · Nature Communications · 9
2022 · Chao Wang, Li Fan, et al. · Nature Communications · 333
2022 · Kaitlin R. Hulce, Priyadarshini Jaishankar, et al. · Cell chemical biology · 13
2022 · Christina K. Psomas, Donald R. Hoover, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 13
Year
Topic